Author

Doris Cooper Mayr

Ludwig-Maximilians-Universität München

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Aarushi Davesar· 1 shared Alexander BurgesiD· 1 shared Alexander Yu. NikitiniD· 1 shared Anca Chelariu-RaicuiD· 1 shared Andrea Flesken‐NikitiniD· 1 shared Andrew K. GodwiniD· 1 shared Anna V. YemelyanovaiD· 1 shared Bastian CzogallaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aarushi Davesar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Comparative single-cell atlases reveal injury-driven tubal epithelial regeneration as a window for ovarian carcinoma initiation

Coulter Q. Ralston, Andrea Flesken‐Nikitin, Dah‐Jiun Fu, Christopher S. Ashe, Blaine A. Harlan, M. Mozammal Hossain, D. Y. Wang, Anna V. Yemelyanova, Elisa Schmoeckel, Andrew K. Godwin, Doris Cooper Mayr, Benjamin D. Cosgrove, Alexander Yu. Nikitin

The paper compares single-cell transcriptomes of mouse and human tubal epithelium to show injury-driven regeneration in humans may contribute to ovarian cancer initiation.

bioRxiv · Mar 30, 2026 · PreprintCancer Biology

Organoid-based modeling of platinum resistance identifies KRT17 as both a response mediator and biomarker for targeted therapy in ovarian cancer

Juliane Reichenbach, Juliana Schmid, Sophia Hierlmayer, Tingyu Zhang, Ilaria Piga, Sophia Geweniger, Jonas Fischer, Aarushi Davesar, Nemanja Vasovic, Anca Chelariu-Raicu, Fabian Bernhard Thaddäus Kraus, Alexander Burges, Bastian Czogalla, Doris Cooper Mayr, Tobias Straub, , Mirjana Kessler

This study identifies KRT17 as a mediator of platinum resistance and a biomarker for targeted therapy in ovarian cancer using organoid models and clinical data.

bioRxiv · Mar 10, 2025 · PreprintCancer Biology